• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Dendreon Corp

+ Add to Watchlist


0.790 EUR 0.042 5.05%

As of 09:11:30 ET on 10/24/2014.

Snapshot for Dendreon Corp (DNR)

Open: 0.810 Day's Range: 0.790 - 0.827 Volume: 0
Previous Close: 0.832 52wk Range: 0.690 - 2.544 1-Yr Rtn: -55.84%

Stock Chart for DNR

No chart data available.
  • DNR:GR 0.827
  • 1D
  • 1M
  • 1Y
Interactive DNR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DNR

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -0.5800
Est. PEG Ratio -
Market Cap (M EUR) 126.65
Shares Outstanding (M) 160.31
30 Day Average Volume 3,915
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/12/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DNR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for DNR

Dendreon Corporation discovers and develops immunologically based therapeutic products for the treatment of cancer. The Company combines knowledge in immunology and antigen engineering with proprietary cell separation technologies to develop therapeutic vaccines that induce cell-mediated immunity, the body's key defense against cancer.

Douglas G Watson "Doug"ChairmanW Thomas Amick "Tom"President/CEO
Andrew S SandlerExec VP/Chief Medical OfficerGregory R CoxInterim CFO/VP:Finance
More Company Profile & Key Executives for DNR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil